120. Recently US FDA approved CAR-T treatment is a
1. Monoclonal antibody therapy
2. Cell therapy
3. Small molecule therapy
4. Photoactive agent based therapy
FDA-Approved CAR-T Treatment: A Revolutionary Cell Therapy for Cancer
In recent years, the FDA has approved CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) as a groundbreaking treatment for certain types of cancers. Unlike traditional cancer treatments, CAR-T is a form of cell therapy that harnesses the power of the body’s immune system to target and destroy cancer cells.
What is CAR-T Cell Therapy?
CAR-T therapy involves modifying a patient’s own T-cells, a type of immune cell, to express a receptor that recognizes cancer cells. These modified T-cells, equipped with a chimeric antigen receptor (CAR), are then infused back into the patient’s body. Once in the body, the CAR-T cells seek out and attack the cancer cells that carry the target antigen.
How Does CAR-T Work?
-
T-Cell Collection: The process starts with the collection of T-cells from the patient’s blood.
-
Genetic Modification: The collected T-cells are genetically modified in the laboratory to express a receptor (CAR) that recognizes specific proteins on the surface of cancer cells.
-
Infusion into the Patient: After modification, the engineered T-cells are infused back into the patient’s bloodstream.
-
Cancer Cell Targeting: The CAR-T cells then identify and destroy cancer cells that express the targeted antigen.
Why Is CAR-T Therapy a Cell Therapy?
CAR-T therapy is classified as a cell therapy because it involves the modification and reinfusion of living cells (the T-cells) to treat a disease. Unlike traditional therapies such as monoclonal antibody therapy or small molecule therapy, which use external agents to target cancer cells, CAR-T therapy uses the patient’s own immune cells, offering a more personalized treatment approach.
FDA Approval and Impact
The FDA has approved several CAR-T therapies for treating certain cancers, including certain types of lymphomas and leukemias. CAR-T therapy has shown impressive results, especially in patients who have not responded to traditional treatments. It represents a new era of immunotherapy, where the immune system itself is used as a weapon against cancer.
Conclusion: CAR-T Therapy – A Game-Changer in Cancer Treatment
The FDA’s approval of CAR-T cell therapy marks a significant advancement in cancer treatment. As a form of cell therapy, CAR-T offers a powerful and personalized option for patients, giving hope to those with otherwise treatment-resistant cancers.
SEO Keywords: CAR-T therapy, FDA-approved CAR-T, cell therapy, cancer treatment, immunotherapy, chimeric antigen receptor
